Turkey Tail (Trametes versicolor)

Turkey Tail (Trametes versicolor) holds a distinction no other mushroom in this list can claim: one of its primary active compounds, PSK (polysaccharide-K, also called Krestin), was approved as a prescription anti-cancer adjuvant drug in Japan in 1977 and has been used clinically there ever since. This is not wellness marketing — it is regulatory approval based on over 40 human clinical trials. PSK and its close analog PSP (polysaccharide peptide) are beta-glucan-rich compounds that exert immunomodulatory effects through multiple parallel pathways: stimulation of natural killer (NK) cells, enhancement of dendritic cell maturation, promotion of Th1-type immune polarization, and activation of both complement cascades and adaptive B-cell responses. The clinical trial evidence across cancer types is substantial. A meta-analysis of 38 randomized controlled trials involving 3,117 lung cancer patients showed chemotherapy combined with PSK improved response rate to 56.9% versus 43.3% for chemotherapy alone. Colorectal cancer patients on PSK alongside oral chemotherapy demonstrated superior survival at both 5 and 10 years in multiple studies. In a Phase I breast cancer trial, participants taking 6 or 9 grams of Turkey Tail daily for six weeks showed significant increases in CD8+ cytotoxic T cells and CD19+ B cells — direct immune activation confirmed by cell count. The FDA has not approved PSK as a cancer treatment, but the NCI has funded Turkey Tail trials through major academic cancer centers. For general immune support outside oncology contexts, Turkey Tail's prebiotic polysaccharides also feed beneficial gut bacteria including Lactobacillus and Bifidobacterium species, creating a gut-immune axis benefit that is increasingly recognized as central to overall immune competence. Dosing for general immune support is 1,000–3,000 mg daily; clinical oncology protocols have used up to 6–9 grams. Host Defense Turkey Tail is ~$29.99 for 60 capsules. Safety is excellent with no documented serious adverse events in healthy populations.